Embedded Files
Pioneering Research with a Global Impact
Pioneering Research with a Global Impact
The University of Alberta’s CTO is committed to advancing clinical research that makes a difference in the lives of people worldwide. Our research is guided by a commitment to ethical practices, scientific rigor, and inclusivity.
Research Spotlight
Research Spotlight
Past, Present and Future of Hepatitis Research at the U of A
Past, Present and Future of Hepatitis Research at the U of A
As we mark World Hepatitis Day 2025, we at the Clinical Trials Office (CTO) are proud to launch a new video series spotlighting the University of Alberta’s contributions to the global fight against hepatitis B and C, alongside decades of international collaboration - from groundbreaking discovery to global impact, and now, to vaccine development.
Part 1: Discovery
Part 1: Discovery
This first installment recognizes that viral hepatitis is a global health challenge met by a global research community - from pioneering Canadian work on lamivudine (3TC) at Biochem Pharma and McGill University, to the discovery of hepatitis C and its key diagnostic tools at Chiron Corporation in the U.S., to major curative therapeutic breakthroughs by Gilead, Bristol-Myers Squibb, AbbVie, and landmark research by Rockefeller University, Heidelberg University, and others.
Research Areas
Research Areas
The University of Alberta is home to specialized institutes, departments, and research groups working on research with the potential to improve health across therapeutic areas. Learn more below about some of the research areas and the researchers making a difference.
Innovation Spotlight
Innovation Spotlight
Study Results and Publications
Study Results and Publications
Select results of research from investigators across the U of A.
Select results of research from investigators across the U of A.
Page updated
Report abuse